FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890201119> ?p ?o ?g. }

• W2890201119 endingPage "9" @default.
• W2890201119 startingPage "1" @default.
• W2890201119 abstract "The blood-brain barrier (BBB) is suggested to be compromised in Alzheimer's disease (AD). The concomitant presence of vascular amyloid beta (Aβ) pathology, so called cerebral amyloid angiopathy (CAA), also predisposes impairment of vessel integrity. Additionally, immunotherapy against Aβ may lead to further damage of the BBB. To what extent this affects the BBB passage of molecules is debated. The current study aimed to investigate BBB integrity to large molecules in transgenic mice displaying abundant Aβ pathology and age matched wild type animals, with or without acute anti-Aβ antibody treatment. Animals were administered a single i.v. injection of PBS or 3D6 (10 mg/kg), i.e. the murine version of the clinically investigated Aβ antibody bapineuzumab, supplemented with [125I]3D6. Three days post injections, a 4 kDa FITC and a 150 kDa Antonia Red dextran were administered i.v. to all animals. After termination, fluorescent detection in brain and serum was used for the calculation of dextran brain-to-blood concentration ratios. Further characterization of antibody fate and the presence of CAA were investigated using radioactivity measurements and Congo red staining. BBB passage of large molecules was equally low in wild type and transgenic mice, suggesting an intact BBB despite Aβ pathology. Neither was the BBB integrity affected by acute 3D6 treatment. However, CAA was confirmed in the transgenes and local antibody accumulations were observed in the brain, indicating CAA-antibody interactions. The current study shows that independently of Aβ pathology or acute 3D6 treatment, the BBB is intact, without extensive permeability to large molecules, including the 3D6 antibody." @default.
• W2890201119 created "2018-09-27" @default.
• W2890201119 creator A5002561088 @default.
• W2890201119 creator A5021000758 @default.
• W2890201119 creator A5051540682 @default.
• W2890201119 creator A5055348919 @default.
• W2890201119 creator A5081371265 @default.
• W2890201119 creator A5083057175 @default.
• W2890201119 creator A5091428143 @default.
• W2890201119 date "2018-12-01" @default.
• W2890201119 modified "2023-10-06" @default.
• W2890201119 title "Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy" @default.
• W2890201119 cites W1517090607 @default.
• W2890201119 cites W1540282518 @default.
• W2890201119 cites W1567490604 @default.
• W2890201119 cites W1852676216 @default.
• W2890201119 cites W1893651774 @default.
• W2890201119 cites W1978924496 @default.
• W2890201119 cites W1982206682 @default.
• W2890201119 cites W2002520289 @default.
• W2890201119 cites W2013775559 @default.
• W2890201119 cites W2021255508 @default.
• W2890201119 cites W2025061302 @default.
• W2890201119 cites W2029695041 @default.
• W2890201119 cites W2030641075 @default.
• W2890201119 cites W2034275438 @default.
• W2890201119 cites W2047883284 @default.
• W2890201119 cites W2053035647 @default.
• W2890201119 cites W2059631065 @default.
• W2890201119 cites W2063038783 @default.
• W2890201119 cites W2063309386 @default.
• W2890201119 cites W2063808031 @default.
• W2890201119 cites W2071079524 @default.
• W2890201119 cites W2080938528 @default.
• W2890201119 cites W2086572083 @default.
• W2890201119 cites W2094113864 @default.
• W2890201119 cites W2095690392 @default.
• W2890201119 cites W2099540110 @default.
• W2890201119 cites W2100951990 @default.
• W2890201119 cites W2120520848 @default.
• W2890201119 cites W2122843800 @default.
• W2890201119 cites W2130945756 @default.
• W2890201119 cites W2150231759 @default.
• W2890201119 cites W2152222652 @default.
• W2890201119 cites W2158547909 @default.
• W2890201119 cites W2160676126 @default.
• W2890201119 cites W2164535032 @default.
• W2890201119 cites W2170241219 @default.
• W2890201119 cites W2198664180 @default.
• W2890201119 cites W2274785614 @default.
• W2890201119 cites W2415637550 @default.
• W2890201119 cites W2490908868 @default.
• W2890201119 cites W2509488704 @default.
• W2890201119 cites W2510806376 @default.
• W2890201119 cites W2565411144 @default.
• W2890201119 cites W2569480372 @default.
• W2890201119 cites W2743948486 @default.
• W2890201119 cites W2755745480 @default.
• W2890201119 cites W2766168937 @default.
• W2890201119 cites W2766949297 @default.
• W2890201119 cites W2805716415 @default.
• W2890201119 cites W2885935586 @default.
• W2890201119 doi "https://doi.org/10.1016/j.neuropharm.2018.09.001" @default.
• W2890201119 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30201212" @default.
• W2890201119 hasPublicationYear "2018" @default.
• W2890201119 type Work @default.
• W2890201119 sameAs 2890201119 @default.
• W2890201119 citedByCount "27" @default.
• W2890201119 countsByYear W28902011192019 @default.
• W2890201119 countsByYear W28902011192020 @default.
• W2890201119 countsByYear W28902011192021 @default.
• W2890201119 countsByYear W28902011192022 @default.
• W2890201119 countsByYear W28902011192023 @default.
• W2890201119 crossrefType "journal-article" @default.
• W2890201119 hasAuthorship W2890201119A5002561088 @default.
• W2890201119 hasAuthorship W2890201119A5021000758 @default.
• W2890201119 hasAuthorship W2890201119A5051540682 @default.
• W2890201119 hasAuthorship W2890201119A5055348919 @default.
• W2890201119 hasAuthorship W2890201119A5081371265 @default.
• W2890201119 hasAuthorship W2890201119A5083057175 @default.
• W2890201119 hasAuthorship W2890201119A5091428143 @default.
• W2890201119 hasBestOaLocation W28902011191 @default.
• W2890201119 hasConcept C102230213 @default.
• W2890201119 hasConcept C104317684 @default.
• W2890201119 hasConcept C126322002 @default.
• W2890201119 hasConcept C134018914 @default.
• W2890201119 hasConcept C141035611 @default.
• W2890201119 hasConcept C142724271 @default.
• W2890201119 hasConcept C159654299 @default.
• W2890201119 hasConcept C203014093 @default.
• W2890201119 hasConcept C2777701055 @default.
• W2890201119 hasConcept C2777790613 @default.
• W2890201119 hasConcept C2778402981 @default.
• W2890201119 hasConcept C2779134260 @default.
• W2890201119 hasConcept C2779483572 @default.
• W2890201119 hasConcept C2779703115 @default.
• W2890201119 hasConcept C502032728 @default.
• W2890201119 hasConcept C529278444 @default.

• next